Creteil, France

Pierre Leproust



 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Location History:

  • Créteil, FR (2006)
  • Creteil, FR (2014 - 2015)

Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pierre Leproust: Innovator in Optical Enantiomers

Introduction

Pierre Leproust is a notable inventor based in Créteil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optical enantiomers. With a total of 3 patents to his name, Leproust's work has had a considerable impact on the industry.

Latest Patents

One of his latest patents is a process for the preparation of and crystalline forms of optical enantiomers of modafinil. This invention relates to a polymorphic form of (−)-modafinil that produces a powder X-ray diffraction spectrum comprising intensity peaks corresponding to interplanar spacings of about 14.14, 10.66, 7.80, and 4.02 Å. This innovative approach enhances the understanding and application of modafinil in various therapeutic contexts.

Career Highlights

Throughout his career, Pierre Leproust has worked with prominent companies such as Teva Santé and Cephalon France. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and patenting processes.

Collaborations

Leproust has collaborated with several professionals in his field, including Olivier Neckebrock and Laurent Courvoisier. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

In summary, Pierre Leproust is a distinguished inventor whose work in optical enantiomers has led to significant advancements in pharmaceuticals. His contributions continue to influence the industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…